Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Brentuximab vedotin (SGN-35) treatment in relapsed CD30-positive Hodgkin's lymphoma patients following allogeneic stem cell transplant: a multi-centre case series Gopal, A. K., Ramchandren, R., Berryman, R. B., Advani, R. H., Chen, R., Smith, S., Cooper, M., Engert, A., Matous, J., Zain, J., Grove, L. E., Hunder, N. N., O'Connor, O. A. NATURE PUBLISHING GROUP. 2011: S36
View details for Web of Science ID 000289195400086